期刊文献+

氟达拉滨化疗后继发单纯红细胞再生障碍性贫血三例并文献复习 被引量:4

原文传递
导出
摘要 目的研究氟达拉滨继发单纯红细胞再生障碍性贫血(PRCA)的临床特点及治疗方法。方法回顾分析3例氟达拉滨继发PRCA病例资料,并复习相关文献。结果3例在化疗后1~6个疗程出现PRCA,需要输血治疗,并需要停止原发病的治疗。结论氟达拉滨继发PRCA,一旦出现,通常治疗困难,并会延误原发病的治疗。目前有用利妥昔单抗治疗成功的报道。氟达拉滨导致PRCA的机制目前还不清楚,需要进一步研究。
出处 《白血病.淋巴瘤》 CAS 2011年第7期430-432,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献10

  • 1邓秀芝,王毅力,高健.以氟达拉滨为主的联合方案治疗慢性淋巴细胞增殖性疾病10例[J].白血病.淋巴瘤,2010,19(9):562-564. 被引量:2
  • 2Djaidetti M, Blay A, Bergman M, et al. Pure red cell aplasia-a rare disease with multiple causes. Biomed Pharmacother, 2003, 57: 326- 332.
  • 3Hirokaw M, Sawada K, Fujishima N, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol, 2009, 84: 144-148.
  • 4Leporrier M, Reman O, Troussard X. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia. Lancet, 1993, 342: 555.
  • 5Johnson S, Smith AG, Loffler H, et al. Muhicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet, 1996, 347: 1432-1438.
  • 6Ha.ssan G. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood, 2002, 99:1092-1094.
  • 7VeeIken H, Wasch R, Behringer D, et al. Pure red ceil aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant, 2000, 26:911-915.
  • 8Fujiwara T, Yamada M, Miyamura K, et al. Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell ap|asia. Int J Hematol, 2004, 79: 293-297.
  • 9Gautam B, Susan O, William G, et al. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab-incidence and predictors. Bri J Haematol, 2007, 136: 800-805.
  • 10Au WY, Lain CC, Chim CS, et al. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia. Leuk Res, 2005, 29: 1213-1215.

二级参考文献9

  • 1Reed DN Jr,Vitale GC,Martin R,et al.Bileduct carcinoma:trends in treatment in the nineties.Am Surg,2000,66:711-714.
  • 2Grever MR,Kopecky,Coltman CA,et al.Fludarabine monophosphate:a potentially useful agent in chronic lymphocytic leukemia.Nouv Rev Fr Hemutol,1988,30:451-459.
  • 3O'Brien S,Kantarjian H,Beran M,et al.Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis derived prognostic model for response to treatment.Blood,1993,82:1695-1700.
  • 4Adkins JC,Peters Dn,Markham A.Fludarabine An update of its pharmacology and use in the treatment of haematological malignancies.Drugs,1997,53:1005-1037.
  • 5Keating MJ,O'Briens,Lerners,et al.Long term followup of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy.Blood,1998,92:1165-1171.
  • 6Bellosillo B,Villamor N,Colomer D,et al.In vitro evolution of fludarabine in combination with cyclophosphamide and /or mitoxantrone in B-cell chronic lymphocytic leukemia.Blood,1999,94:2836-2843.
  • 7Aksoy S,Abali H,Kilickap S,et al.Fludarabine phosphate may be useful in the treatment of graft-Versus-host disease.Med Hypotheses,2005,64:1150-1152.
  • 8吕书晴,王健民,宋献民,陈莉,许晓倩,章卫平,侯军,邱慧颖,黄崇媚,杨建民.含氟达拉滨的联合化疗方案治疗慢性淋巴细胞白血病/小淋巴细胞性淋巴瘤[J].临床肿瘤学杂志,2008,13(2):119-122. 被引量:4
  • 9钱林生,郝长来.慢性淋巴细胞增殖性疾病及其分类[J].中国实用内科杂志,2001,21(6):321-323. 被引量:3

共引文献1

同被引文献20

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部